Home
Conditions
Immunologic Deficiency Syndromes

Clinical trial condition

Immunologic Deficiency Syndromes

Explore clinical trials studying Immunologic Deficiency Syndromes. Study availability and eligibility vary by location and protocol.

6,128 public trials 394 recruiting studies

Refine in advanced search Browse all conditions

Immunologic Deficiency Syndromes trial results

Completed

Safety and Efficacy Study of Vaccine Schedule With Ad26.Mos.HIV and MVA-Mosaic in Human Immunodeficiency Virus (HIV)-Infected Adults

NCT02919306

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Bangkok, Thailand

View Trial Details

Completed

Feasibility of Positive Links for Youth Care Engagement Intervention

NCT05689515

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +13 more
Locations: University Health Center Downtown San Antonio, Texas, United States

View Trial Details

Completed

A Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Modified Vaccinia Ankara (MVA)-Mosaic OR Ad26.Mos4.HIV Plus a Combination of Mosaic and Clade C gp140 Protein in Human Immunodeficiency Virus (HIV) Type 1 Infected Adults on Suppressive Antiretroviral Treatment

NCT03307915

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Safety, Tolerability and Immunogenicity Study of Different Vaccine Schedules With Ad26.Mos.HIV and Clade C Glycoprotein (gp)140 in Healthy Human Immunodeficiency Virus (HIV)-Uninfected Adults

NCT02685020

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Boston, Massachusetts, United States

View Trial Details

Completed

A Bioequivalence Study of Darunavir, Emtricitabine, and Tenofovir Alafenamide, in the Presence of Cobicistat in Healthy Participants

NCT02578550

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Groningen, Netherlands

View Trial Details

Completed

An Open-label, Non-randomized, Single-arm Study to Investigate the Mechanism(s) by Which Nevirapine Increases Plasma HDL in HIV+ Subjects

NCT00144261

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: 1100.1426.01 Academic Medical Centre Amsterdam, Netherlands

1100.1426.02 Onze Lieve Vrouwe Gasthuis Amsterdam, Netherlands

1100.1426.44001 Boehringer Ingelheim Investigational Site London, United Kingdom

View Trial Details

Completed

Aging With HIV and Neurocognitive Decline, a Follow-up Study

NCT05385588

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Hôpital Pellegrin Bordeaux, France

Hôpital Saint André Bordeaux, France

CH Cannes Cannes, France

CHD Vendée La Roche-sur-Yon, France

View Trial Details

Completed

Zepatier in Patients with Substance Use

NCT04048850

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Chemically-Induced Disorders, +25 more
Locations: University of Illinois at Chicago Chicago, Illinois, United States

View Trial Details

Completed

COVID-19 Serology in People Living with HIV in Hong Kong

NCT05028881

Conditions: Blood-Borne Infections, COVID-19, Coinfection, +23 more
Locations: Shui Shan Lee Hong Kong, China

View Trial Details

Completed

A Combination Efficacy Study in Africa of Two DNA-MVA-Env Protein or DNA-Env Protein HIV-1 Vaccine Regimens With PrEP

NCT04066881

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: MRC/UVRI and LSHTM Uganda Research Unit Entebbe, Uganda

View Trial Details

Immunologic Deficiency Syndromes

Immunologic Deficiency Syndromes trial results

Related conditions